ID

21388

Beschreibung

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: ABC-Containing Product Discontinuation Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Stichworte

Versionen (1)
  1. 19.04.17 19.04.17 -
Hochgeladen am

19. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Genetic Screening For HLA-B*5701 in Patients with HIV ABC-Containing Product Discontinuation NCT00340080

Englisch

Genetic Screening For HLA-B*5701 ABC-Containing Product Discontinuation NCT00340080

1 Formulare  
ABC-Containing Product Discontinuation
Beschreibung

ABC-Containing Product Discontinuation

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0663655
UMLS CUI-3
C0850893
Subject Identifier
Beschreibung

Subject Identifier

Datentyp

text

Alias
UMLS CUI [1]
C2348585
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
Beschreibung

Ziagen stopped

Datentyp

text

Alias
UMLS CUI [1,1]
C0724476
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Ziagen:
Beschreibung

If Yes, 􏰀check the primary reason the ABC-Containing Product was stopped

Datentyp

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0724476
Primary reason the ABC-Containing Product was stopped, Ziagen:
Beschreibung

If Other, please specify

Datentyp

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0724476
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
Beschreibung

Trizivir stopped

Datentyp

text

Alias
UMLS CUI [1,1]
C0939514
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Trizivir:
Beschreibung

primary reason Trizivir was stopped

Datentyp

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0939514
Primary reason the ABC-Containing Product was stopped, Trizivir:
Beschreibung

If Other, please specify

Datentyp

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0939514
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
Beschreibung

Kivexa stopped

Datentyp

text

Alias
UMLS CUI [1,1]
C1567988
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Kivexa:
Beschreibung

primary reason Kivexa was stopped

Datentyp

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1567988
Primary reason the ABC-Containing Product was stopped, Kivexa:
Beschreibung

If Other, please specify

Datentyp

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1567988
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Genetic Screening For HLA-B*5701 ABC-Containing Product Discontinuation NCT00340080

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
ABC-Containing Product Discontinuation
C0013227 (UMLS CUI-1)
C0663655 (UMLS CUI-2)
C0850893 (UMLS CUI-3)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
text
C0724476 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Ziagen:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Ziagen:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Ziagen was stopped
Item
Primary reason the ABC-Containing Product was stopped, Ziagen:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
text
C0939514 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Trizivir:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Trizivir:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Trizivir was stopped
Item
Primary reason the ABC-Containing Product was stopped, Trizivir:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
text
C1567988 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Kivexa:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Kivexa:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Kivexa was stopped
Item
Primary reason the ABC-Containing Product was stopped, Kivexa:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video